Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals. Journal of Pharmaceutical Negative Results [Internet]. 2022 Nov. 14 [cited 2026 Jun. 6];:921-9. Available from: https://www.pnrjournal.com/index.php/home/article/view/3403